IllumiCore 50 mg
IllumiCore 50 mg is an advanced nootropic formulation that combines four neuroactive peptides studied for neuroprotection, cognitive enhancement, memory, learning, and stress resilience. The synergy between PE-22-28, Pinealon, N-Acetyl Semax, and N-Acetyl Selank makes this blend a highly versatile research tool aimed at studying neurocognitive systems and the mechanisms regulating neuronal plasticity.
Una formulazione nootropica avanzata
IllumiCore 50 mg originates from the idea of combining four molecules independently studied in the neurobiological field, creating a single solution capable of acting on multiple pathways involved in cognitive functions. Contemporary research suggests that the combined action of peptides with anxiolytic, neuromodulatory, trophic, and anti-inflammatory properties may offer a unique window into the complex mechanisms regulating mood, memory, learning, and adaptive stress.
The controlled blend in precise proportions allows researchers to analyze complementary effects on: attention, mental focus, synaptic plasticity, neuroprotection, neurochemical balance, and behavioral stress responses.
PE-22-28 (10 mg)
PE-22-28 is a peptide fragment derived from the neuroactive regions of a cerebral protein precursor. Preclinical studies explore its potential role in mood modulation, neurosignaling processes, and the optimization of interneuronal communication. Research suggests that this peptide may influence pathways related to emotional regulation and behavioral stability, particularly under stress and cognitive overload.
Pinealon (10 mg)
Pinealon is a short tripeptide studied for its ability to support memory, learning, and cognitive protection, especially in models simulating aging and neurofunctional decline. Scientific literature indicates that Pinealon may contribute to neuron protection from oxidative and inflammatory processes, promoting strong neuroplasticity mechanisms. It is often analyzed in research contexts related to executive functions, processing speed, and the preservation of cognitive abilities over time.
N-Acetyl Semax (20 mg)
N-Acetyl Semax is an acetylated variant of the Semax peptide, characterized by improved stability and enhanced properties compared to the original molecule. Preclinical studies indicate that it may support: neuroprotection, learning, long-term memory, attention, and mental stress resistance. It is associated with modulation of BDNF (Brain-Derived Neurotrophic Factor), a crucial element for neuronal growth and the formation of new synaptic connections.
The acetylated variant shows a longer half-life and better bioavailability compared to the standard form, making it an interesting research subject for advanced cognitive performance models.
N-Acetyl Selank (8 mg)
N-Acetyl Selank represents the enhanced version of the peptide Selank, studied to improve stability, duration, and penetration into biological systems. It is examined for its effects on anxiety reduction, mood regulation, immune modulation, and enhanced stress resilience.
Numerous preclinical models indicate that N-Acetyl Selank influences: GABAergic neurotransmission, stress responses, emotional homeostasis, and processes of neurobehavioral adaptation</strong
Synergy of the four peptides
The combination of the four compounds creates a multi-target research profile that allows simultaneous investigation of: synaptic plasticity, neuronal protection, stress regulation, learning, and executive functions.
IllumiCore 50 mg allows researchers to study: synergistic interactions between neuropeptide systems, cognitive adaptation models, anti-stress mechanisms, neurochemical balance, neuronal trophic processes.
The presence of anxiolytic peptides (N-Acetyl Selank), cognitive peptides (N-Acetyl Semax), protective peptides (Pinealon), and mood-modulating peptides (PE-22-28) offers an advanced platform to understand how different brain systems interact to support cognitive functions and neuronal health.
Components per vial
Total composition: 50 mg
• PE-22-28: 10 mg • Pinealon: 10 mg • N-Acetyl Semax: 20 mg • N-Acetyl Selank: 8 mg
Notes and Warnings
IllumiCore 50 mg is intended exclusively for laboratory research use. Not for human use.






